New trial to test potential treatment for chronic kidney disease
Posted:
The first participants have been recruited in Oxford for a new multinational clinical trial that will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD).
eMurmur, an Ontario-based artificial intelligence (AI) startup, has received U.S. Food and Drug Administration (FDA) clearance for its suite of algorithms designed to evaluate heart recordings captured by digital stethoscopes.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us